Stocks GTM Financial statements
Financial statementsZoomInfo Technologies Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data ZoomInfo Technologies Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 144 | 293 | 476 | 747 | 1,098 | 1,240 | 1,214 | 1,250 |
| Gross profit | 107 | 225 | 369 | 611 | 909 | 1,061 | 1,025 | 1,050 |
| Research and development | 6.1 | 30.1 | 51.4 | 120 | 207 | 192 | 196 | 182 |
| Selling and marketing | 42.4 | 90.2 | 185 | 241 | 379 | 409 | 414 | 415 |
| General and administrative | 20.8 | 35.1 | 62.8 | 92.4 | 125 | 180 | 295 | 207 |
| Operating expenses | 79.9 | 189 | 332 | 497 | 734 | 802 | 927 | 824 |
| Operating income | 26.6 | 36.1 | 37.1 | 113 | 176 | 260 | 97.4 | 226 |
| Interest expense | 58.2 | 102 | 69.3 | 43.9 | 47.6 | 45.2 | 39.3 | 42.6 |
| Other non-operating income | 0.1 | 0 | 15.4 | 39.3 | 66.4 | 179 | -26.1 | 11.2 |
| Pre-tax income | -31.5 | -84.5 | -31.7 | 101 | 195 | 389 | 31.3 | 194 |
| Income tax | -2.9 | -6.5 | 4.7 | 6.1 | 131 | 282 | 2.2 | 70.1 |
| Net income to minority interests | 0 | 0 | -27.3 | -21.9 | 0 | 0 | ||
| Net income | 0 | 0 | -4 | 117 | 63.2 | 107 | 29.1 | 124 |
| EBITDA | 29.2 | 42.2 | 46 | 127 | 193 | 279 | 123 | 256 |
| EPS, basic | -0.10 | 0.46 | 0.16 | 0.27 | 0.08 | 0.38 | ||
| EPS, diluted | -0.11 | 0.43 | 0.16 | 0.27 | 0.08 | 0.38 | ||
| Shares, basic (weighted) | 401 | 397 | 362 | 324 | ||||
| Shares, diluted (weighted) | 403 | 397 | 362 | 324 |
Balance sheet
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9 | 41.4 | 270 | 308 | 418 | 447 | 140 | 176 |
| Short-term investments | 0 | 30.6 | 18.4 | 128 | 82.2 | 0 | 4 | |
| Receivables | 86.9 | 121 | 187 | 223 | 272 | 246 | 226 | |
| Other current assets | 8.3 | 14.3 | 27.1 | 57.8 | 59.6 | 65 | 48.5 | |
| Total current assets | 148 | 440 | 546 | 832 | 864 | 451 | 454 | |
| Property, plant and equipment | 23.3 | 31 | 41.7 | 52.1 | 65.1 | 113 | 163 | |
| Lease right-of-use assets | 36.8 | 32 | 59.8 | 63 | 80.7 | 90.9 | 113 | |
| Goodwill | 446 | 967 | 1,000 | 1,575 | 1,693 | 1,693 | 1,693 | 1,693 |
| Intangible assets | 371 | 366 | 431 | 396 | 335 | 276 | 217 | |
| Total assets | 1,562 | 2,327 | 6,853 | 7,136 | 6,868 | 6,468 | 6,440 | |
| Accounts payable | 7.9 | 8.6 | 15.9 | 35.6 | 34.4 | 16.6 | 31.3 | |
| Accrued liabilities | 62.9 | 81.5 | 103 | 104 | 114 | 124 | 115 | |
| Deferred revenue | 158 | 221 | 362 | 417 | 440 | 474 | 475 | |
| Short-term debt | 8.7 | 0 | 0 | 0 | 6 | 5.9 | 5.9 | |
| Total current liabilities | 242 | 321 | 508 | 573 | 638 | 652 | 633 | |
| Long-term debt | 1,195 | 745 | 1,233 | 1,236 | 1,226 | 1,222 | 1,318 | |
| Lease liabilities | 40.7 | 33.6 | 61.5 | 67.9 | 89.9 | 151 | 239 | |
| Other non-current liabilities | 14.3 | 7.8 | 2.8 | 5.5 | 3.5 | 2.3 | 1.7 | |
| Total liabilities | 1,576 | 1,388 | 4,855 | 4,865 | 4,749 | 4,774 | 4,931 | |
| Total debt | 1,203 | 745 | 1,233 | 1,236 | 1,232 | 1,228 | 1,324 | |
| Paid-in capital | 0 | 505 | 1,872 | 2,052 | 1,805 | 1,363 | 1,068 | |
| Retained earnings | 0 | -4 | 113 | 176 | 283 | 312 | 437 | |
| Other comprehensive income | -6 | -2.4 | 9.5 | 39.7 | 27.3 | 14.8 | 1 | |
| Shareholders' equity | 1,998 | 2,272 | 2,119 | 1,694 | 1,509 | |||
| Minority interests | 0 | 437 | 0 | |||||
| Total equity | -119 | -214 | 940 | 1,998 | 2,272 | 2,119 | 1,694 | 1,509 |
| Total liabilities and equity | 1,562 | 2,327 | 6,853 | 7,136 | 6,868 | 6,468 | 6,440 | |
| Shares outstanding | 403 | 404 | 385 | 342 | 307 |
Cash flow statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | -28.6 | -78 | -36.4 | 94.9 | 63.2 | 107 | 29.1 | 124 |
| Depreciation and amortization | 2.6 | 6.1 | 8.9 | 13.7 | 17.6 | 19.6 | 25.9 | 30.3 |
| Stock-based compensation | 32.7 | 25.1 | 122 | 93 | 192 | 168 | 138 | 116 |
| Deferred income tax | -3 | -7.2 | -1.8 | -14.5 | 123 | 277 | -5.9 | 61.4 |
| Change in receivables | -8.9 | -34.5 | -32.9 | -66.1 | -39.3 | -82.8 | -16.9 | -0.4 |
| Change in payables | -0.3 | 5.1 | -0.2 | 4.6 | 19.5 | -1.8 | -17.7 | 10.3 |
| Cash from operations | 43.8 | 44.4 | 170 | 299 | 417 | 435 | 369 | 465 |
| Capital expenditures | -4.6 | -13.6 | -16.8 | -23.6 | -28.9 | -26.5 | -64.9 | -76.1 |
| Acquisitions | -8.5 | -723 | -65.9 | -684 | -144 | 0 | -0.5 | 0 |
| Purchases of investments | 0 | 0 | -30.6 | -120 | -139 | -145 | 0 | -15.2 |
| Cash from investing | -13.1 | -737 | -113 | -696 | -281 | 24.4 | 13.4 | -80.8 |
| Debt issued | 67.3 | 1,221 | 35 | 1,072 | 0 | 0 | ||
| Debt repaid | -3.7 | -650 | -511 | -581 | 0 | -6 | -5.9 | -5.9 |
| Stock issued | 0 | 0 | 2.1 | 1.3 | 0.4 | 0 | 0 | |
| Share buybacks | 0 | 0 | -400 | -566 | -411 | |||
| Cash from financing | -29.9 | 726 | 172 | 440 | -25.9 | -427 | -690 | -348 |
| Net change in cash | 0.8 | 33.5 | 229 | 43.1 | 110 | 32.1 | -307 | 36.7 |
| Free cash flow | 39.2 | 30.8 | 153 | 276 | 388 | 408 | 305 | 389 |
| Interest paid | 40.2 | 95 | 66.5 | 33.3 | 50 | 48.5 | 44 | 45.8 |
| Income taxes paid | 0 | 0 | 1.9 | 18.1 | 11.6 | 12.2 | 13.8 | 8.2 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 83.5% | Gross profit / revenue. |
| Operating margin | -35.2% | Operating income / revenue. |
| EBITDA margin | -32.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -37.9% | Pre-tax income / revenue. |
| Net margin | -43.0% | Net income / revenue. |
| FCF margin | 28.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 34.9% | Cash from operations / revenue. |
| Return on equity (ROE) | -65.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -9.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | -18.0% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 14.7% | Research and development expense / revenue. |
| Stock-based pay / revenue | 8.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 6.4% | Capital expenditures / revenue. |
| D&A / revenue | 2.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 2.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 4.4% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 21.3% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 2.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 4.9% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 23.3% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 131.7% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 8.7% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 43.5% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 107.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 9.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 41.0% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 326.8% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 25.3% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 375.0% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 33.4% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 26.0% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 3.7% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 22.4% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 27.8% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 0.1% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 20.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -10.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -12.8% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -0.4% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -3.4% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 22.6% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -10.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -7.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.65x | Current assets / current liabilities. |
| Quick ratio | 0.55x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.25x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 1.53x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 22.3% | Total debt / total assets. |
| Liabilities / assets | 85.4% | Total liabilities / total assets. |
| Net debt | $1.11B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | -8.80x | Operating income / interest expense. |
| Working capital | -$213.0M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 21.7% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$406.2M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.22x | Revenue / average total assets. |
| Fixed asset turnover | 7.20x | Revenue / average property, plant and equipment. |
| Receivables turnover | 6.84x | Revenue / average receivables. |
| Days sales outstanding | 53 days | 365 x average receivables / revenue. |
| Capex / operating cash flow | 18.4% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$1.84 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $4.27 | Revenue / diluted weighted shares. |
| FCF per share | $1.22 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.49 | Cash from operations / diluted weighted shares. |
| Book value per share | $2.83 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$1.39 | Tangible book value / shares outstanding. |
| Cash per share | $0.51 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 80.7% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.09B | Share price x shares outstanding. |
| Enterprise value | $2.21B | Market cap + total debt - cash - short-term investments. |
| P/S | 0.87x | Market cap / revenue. |
| P/B | 1.32x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 3.05x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 2.49x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.75x | Enterprise value / revenue. |
| EV/FCF | 6.16x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 32.8% | Free cash flow / market cap. |
| Earnings yield | -49.6% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 26.5% | (Dividends paid + share buybacks) / market cap. |
What was ZoomInfo Technologies Inc.'s revenue in fiscal 2025?
ZoomInfo Technologies Inc. reported revenue of $1.25B for fiscal 2025, 2.9% higher than the year before.
Was ZoomInfo Technologies Inc. profitable in fiscal 2025?
Yes. Net income was $124.2M, a net margin of 9.9%.
How much free cash flow did ZoomInfo Technologies Inc. generate in fiscal 2025?
Cash from operations of $465.4M minus capital expenditures of $76.1M left free cash flow of $389.3M.